2022 Q4 Form 10-K Financial Statement
#000149315223010345 Filed on March 31, 2023
Income Statement
Concept | 2022 Q4 | 2022 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $185.7K | $666.3K |
YoY Change | ||
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $185.7K | $666.3K |
YoY Change | 151334.32% | |
Operating Profit | ||
YoY Change | ||
Interest Expense | $1.002M | $100.0K |
YoY Change | ||
% of Operating Profit | ||
Other Income/Expense, Net | $1.677M | |
YoY Change | ||
Pretax Income | $815.9K | $1.010M |
YoY Change | -229707.73% | |
Income Tax | $310.3K | $310.3K |
% Of Pretax Income | 38.03% | 30.71% |
Net Earnings | $505.6K | $700.0K |
YoY Change | -159194.32% | |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | $0.04 | $0.05 |
COMMON SHARES | ||
Basic Shares Outstanding | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q4 | 2022 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $262.8K | $262.8K |
YoY Change | 5155.2% | |
Cash & Equivalents | $262.8K | |
Short-Term Investments | ||
Other Short-Term Assets | $157.6K | $157.6K |
YoY Change | ||
Inventory | ||
Prepaid Expenses | $157.6K | |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $420.4K | $420.4K |
YoY Change | 8307.4% | 8307.4% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $119.0M | $119.0M |
YoY Change | ||
Other Assets | $77.65K | $77.65K |
YoY Change | -42.68% | |
Total Long-Term Assets | $119.1M | $119.1M |
YoY Change | 87792.1% | 87788.85% |
TOTAL ASSETS | ||
Total Short-Term Assets | $420.4K | $420.4K |
Total Long-Term Assets | $119.1M | $119.1M |
Total Assets | $119.5M | $119.5M |
YoY Change | 84962.55% | 84959.53% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $130.2K | $130.2K |
YoY Change | ||
Accrued Expenses | $202.7K | $202.7K |
YoY Change | 1251.4% | |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $144.4K | $144.4K |
YoY Change | 43.17% | |
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $787.6K | $787.6K |
YoY Change | 579.62% | 579.64% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $3.450M | $3.450M |
YoY Change | ||
Total Long-Term Liabilities | $3.450M | $3.450M |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $787.6K | $787.6K |
Total Long-Term Liabilities | $3.450M | $3.450M |
Total Liabilities | $4.238M | $4.238M |
YoY Change | 3556.51% | 3556.61% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$3.230M | |
YoY Change | 737275.34% | |
Common Stock | $0.00 | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$3.229M | $115.2M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $119.5M | $119.5M |
YoY Change | 84962.55% | 84959.53% |
Cashflow Statement
Concept | 2022 Q4 | 2022 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $505.6K | $700.0K |
YoY Change | -159194.32% | |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | -$65.75K | -$601.4K |
YoY Change | ||
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $0.00 | -$117.3M |
YoY Change | ||
Cash From Investing Activities | $0.00 | -$117.3M |
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 0.000 | $118.2M |
YoY Change | 2363082.22% | |
NET CHANGE | ||
Cash From Operating Activities | -65.75K | -$601.4K |
Cash From Investing Activities | 0.000 | -$117.3M |
Cash From Financing Activities | 0.000 | $118.2M |
Net Change In Cash | -65.75K | $257.8K |
YoY Change | 5055.12% | |
FREE CASH FLOW | ||
Cash From Operating Activities | -$65.75K | -$601.4K |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001889450 | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2021Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
usd | |
CY2022Q4 | us-gaap |
Deferred Costs
DeferredCosts
|
usd | |
CY2021Q4 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
usd | |
CY2021Q4 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
usd | |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
usd | |
CY2021Q4 | FTIIU |
Franchise Tax Payable Current
FranchiseTaxPayableCurrent
|
usd | |
CY2021Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
usd | |
CY2021Q4 | FTIIU |
Deferred Underwriting Commission
DeferredUnderwritingCommission
|
usd | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
usd | |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
usd | |
us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
usd | ||
FTIIU |
Franchise Tax
FranchiseTax
|
usd | ||
us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
usd | ||
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
usd | ||
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
usd | |
CY2022 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
usd | |
us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
usd | ||
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
usd | ||
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
usd | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
usd | ||
us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
usd | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | ||
us-gaap |
Proceeds From Sale Of Interest In Partnership Unit
ProceedsFromSaleOfInterestInPartnershipUnit
|
usd | ||
us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
usd | ||
us-gaap |
Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
|
usd | ||
us-gaap |
Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
|
usd | ||
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
usd | |
FTIIU |
Deferred Underwriting Commission Non Cash
DeferredUnderwritingCommissionNonCash
|
usd | ||
CY2022 | FTIIU |
Accrued Deferred Offering Costs
AccruedDeferredOfferingCosts
|
usd | |
FTIIU |
Initial Classification Of Class Common Stock Subject To Redemption
InitialClassificationOfClassCommonStockSubjectToRedemption
|
usd | ||
FTIIU |
Remeasurement Adjustment
RemeasurementAdjustment
|
usd | ||
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2022 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
|
usd | |
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
001-41289 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
FUTURETECH II ACQUISITION CORP. | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
87-2551539 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
128 Gail Drive | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New Rochelle | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10805 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
(914) | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
316-4805 | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2022 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2022 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
true | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
114885000 | usd |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
3686 | |
CY2022 | dei |
Auditor Name
AuditorName
|
Adeptus Partners, LLC | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Ocean, New Jersey | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
262756 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
157614 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
420370 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
5000 | usd |
CY2021Q4 | us-gaap |
Deferred Costs
DeferredCosts
|
135455 | usd |
CY2022Q4 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
118976585 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
77654 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
119474609 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
140455 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
130225 | usd |
CY2022Q4 | FTIIU |
Franchise Tax Payable Current
FranchiseTaxPayableCurrent
|
200000 | usd |
CY2022Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
310259 | usd |
CY2022Q4 | FTIIU |
Accrued Offering Costs Current
AccruedOfferingCostsCurrent
|
2708 | usd |
CY2021Q4 | FTIIU |
Accrued Offering Costs Current
AccruedOfferingCostsCurrent
|
15000 | usd |
CY2022Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
144443 | usd |
CY2021Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
100893 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
787635 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
115893 | usd |
CY2022Q4 | FTIIU |
Deferred Underwriting Commission
DeferredUnderwritingCommission
|
3450000 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
4237635 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
115893 | usd |
CY2022Q4 | FTIIU |
Common Stock Subject To Possible Redemption Shares
CommonStockSubjectToPossibleRedemptionShares
|
11500000 | shares |
CY2022Q4 | us-gaap |
Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
|
10.30 | |
CY2021Q4 | us-gaap |
Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
|
10.30 | |
CY2022Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
118466326 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
24712 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3229704 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-438 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3229352 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24562 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
119474609 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
140455 | usd |
CY2022 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
100000 | usd |
CY2022 | FTIIU |
Franchise Tax
FranchiseTax
|
200000 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
366311 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
438 | usd | |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
666311 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
438 | usd | |
CY2022 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
1676585 | usd |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1676585 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1010274 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-438 | usd | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
310259 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
700015 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-438 | usd | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
25000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-438 | usd | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24562 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24562 | usd |
CY2022 | FTIIU |
Sale Of Units In Initial Public Offering Net Of Offering Costs
SaleOfUnitsInInitialPublicOfferingNetOfOfferingCosts
|
115000000 | usd |
CY2022 | FTIIU |
Offering Costs
OfferingCosts
|
-2239502 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
5200750 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
3450000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
-117300000 | usd |
CY2022 | FTIIU |
Adjustment To Additional Paid In Capital Remeasurement Adjustment
AdjustmentToAdditionalPaidInCapitalRemeasurementAdjustment
|
-1166327 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
700015 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
700015 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3229352 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3229352 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
700015 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-438 | usd | |
CY2022 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
1676585 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
157614 | usd |
CY2022 | FTIIU |
Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
|
200000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
310259 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
77654 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
100225 | usd |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
438 | usd | |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-601354 | usd |
CY2022 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
117300000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-117300000 | usd |
CY2022 | us-gaap |
Proceeds From Sale Of Interest In Partnership Unit
ProceedsFromSaleOfInterestInPartnershipUnit
|
115000000 | usd |
FTIIU |
Proceeds From Issuance Of Class B Common Stock To Sponsor
ProceedsFromIssuanceOfClassBCommonStockToSponsor
|
25000 | usd | |
CY2022 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
5200750 | usd |
CY2022 | FTIIU |
Uw Fee Paid
UwFeePaid
|
-1725000 | usd |
CY2022 | us-gaap |
Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
|
100000 | usd |
CY2022 | us-gaap |
Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
|
100000 | usd |
CY2022 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
316640 | usd |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
20000 | usd | |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
118159111 | usd |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5000 | usd | |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
257756 | usd |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
5000 | usd | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
5000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
262756 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
5000 | usd |
CY2022 | FTIIU |
Deferred Underwriting Commission Non Cash
DeferredUnderwritingCommissionNonCash
|
3450000 | usd |
FTIIU |
Accrued Deferred Offering Costs
AccruedDeferredOfferingCosts
|
15000 | usd | |
CY2022 | FTIIU |
Initial Classification Of Class Common Stock Subject To Redemption
InitialClassificationOfClassCommonStockSubjectToRedemption
|
118553638 | usd |
CY2022 | FTIIU |
Remeasurement Adjustment
RemeasurementAdjustment
|
3929281 | usd |
CY2022 | us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
187993 | usd |
us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
100893 | usd | |
CY2022Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
520075 | shares |
CY2022Q1 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
117300000 | usd |
CY2022Q1 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10.00 | |
CY2022Q4 | FTIIU |
Cash Underwriting Fees
CashUnderwritingFees
|
1725000 | usd |
CY2022Q4 | FTIIU |
Deferred Underwriting Commission
DeferredUnderwritingCommission
|
3450000 | usd |
CY2022Q4 | us-gaap |
Other Deferred Costs Net
OtherDeferredCostsNet
|
513352 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
700000 | usd |
CY2022Q4 | FTIIU |
Percentage Of Aggregate Fair Market Value Of Assets
PercentageOfAggregateFairMarketValueOfAssets
|
0.80 | pure |
CY2022Q4 | FTIIU |
Shares Redemptionof Business Combination Not Completed
SharesRedemptionofBusinessCombinationNotCompleted
|
0.50 | pure |
CY2022Q4 | us-gaap |
Deposits
Deposits
|
1150000 | usd |
CY2022Q4 | us-gaap |
Share Price
SharePrice
|
0.10 | |
CY2022 | us-gaap |
Interest Expense
InterestExpense
|
100000 | usd |
CY2022Q4 | us-gaap |
Share Price
SharePrice
|
0.10 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
262756 | usd |
CY2022Q4 | FTIIU |
Working Capital
WorkingCapital
|
367265 | usd |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_841_eus-gaap--UseOfEstimates_zSolEsGlw9V7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zZob0MC2Nllk">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zYSjyftZEhff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zhqGRsMO2AA4">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $<span id="xdx_90A_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zc3DswuCujeg" title="Cash FDIC insured amount">250,000</span>. At December 31, 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2022Q4 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
262756 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5000 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
117300000 | usd |
CY2022Q4 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10.00 | |
CY2022Q4 | us-gaap |
Assets Held In Trust
AssetsHeldInTrust
|
118976585 | usd |
CY2022Q4 | us-gaap |
Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
|
118466326 | usd |
CY2022 | us-gaap |
Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
|
3929281 | usd |
CY2022Q4 | us-gaap |
Assets Held In Trust
AssetsHeldInTrust
|
118976585 | usd |
CY2022Q3 | FTIIU |
Percentage Of Exercise Tax To Be Imposed
PercentageOfExerciseTaxToBeImposed
|
0.01 | pure |
CY2022Q3 | FTIIU |
Percentage Of Exercise Tax To Be Imposed
PercentageOfExerciseTaxToBeImposed
|
0.01 | pure |
CY2022 | FTIIU |
Administrative Periodic Expense
AdministrativePeriodicExpense
|
10000 | usd |
CY2022 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
100000 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q4 | FTIIU |
Common Stock Subject To Possible Redemption Shares
CommonStockSubjectToPossibleRedemptionShares
|
11500000 | shares |
CY2021Q4 | FTIIU |
Common Stock Subject To Possible Redemption Shares
CommonStockSubjectToPossibleRedemptionShares
|
0 | shares |
CY2022 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.20 | pure |
CY2022Q4 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
CY2022Q4 | FTIIU |
Startup Costs
StartupCosts
|
98101 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
98101 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
98101 | usd |
CY2022 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
310259 | usd |
CY2022 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
98101 | usd |
CY2022 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
98101 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
310259 | usd |
CY2022 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
98101 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | pure |
CY2022 | FTIIU |
Effective Valuation Allowance
EffectiveValuationAllowance
|
-0.098 | pure |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.308 | pure |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |